Methenamine mandelate contraindications

Revision as of 09:10, 9 January 2014 by Mohamed Moubarak (talk | contribs) (Created page with "__NOTOC__ {{Methenamine mandelate}} {{CMG}}; {{AE}} {{MM}} ==Contraindications== Contraindicated in renal insufficiency. Methenamine mandelate, USP should not be used in pat...")
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search
Methenamine mandelate
METHENAMINE MANDELATE® FDA Package Insert
Description
Clinical Pharmacology
Indications and Usage
Contraindications
Warnings and Precautions
Adverse Reactions
Dosage and Administration
How Supplied
Labels and Packages

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]

Contraindications

Contraindicated in renal insufficiency.

Methenamine mandelate, USP should not be used in patients who have previously exhibited hypersensitivity to it.[1]

References

  1. "METHENAMINE MANDELATE TABLET [EDENBRIDGE PHARMACEUTICALS, LLC]". Text " accessdate" ignored (help)

Adapted from the FDA Package Insert.